Cargando…

Critical care capacity during the omicron wave of the COVID-19 pandemic in China: far from enough

Detalles Bibliográficos
Autores principales:	Tu, Wen-Jun, Liu, Yakun, Zeng, Xianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846919/ https://www.ncbi.nlm.nih.gov/pubmed/36684381 http://dx.doi.org/10.1016/j.lanwpc.2023.100689

Ejemplares similares

Focusing on Gastrointestinal Symptoms in COVID-19 Is Far From Enough
por: Liu, Yuzhi, et al.
Publicado: (2021)

Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic
por: Zhang, Xinxin, et al.
Publicado: (2022)

Mechanistic and Epidemiologic Data: When Is Enough Enough?
por: Roberts, R
Publicado: (2002)

Omicron Variant in the Critical Care Units of the Paris Metropolitan Area: The Reality Research Group
por: Vieillard-Baron, Antoine, et al.
Publicado: (2022)

Vaccination plus previous infection: protection during the omicron wave in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Dental Caries in Children During COVID-19 Pandemic - Are We Doing Enough?
por: Jayam, Cheranjeevi, et al.
Publicado: (2021)

Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)

Omicron: A new face of COVID‐19 pandemic
por: Khan, Amjad, et al.
Publicado: (2022)

The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

The challenges of enhancing global preparedness in response to the impending Omicron pandemic
por: Wong, Ngai-Sze, et al.
Publicado: (2022)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
por: Arora, Prerna, et al.
Publicado: (2022)

BF.7 Omicron subvariant in India and China: a raising concern – correspondence
por: Sah, Ranjit, et al.
Publicado: (2023)

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023)

Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
por: Muramoto, Yukiko, et al.
Publicado: (2023)

Angiogenesis in Regenerative Dentistry: Are We Far Enough for Therapy?
por: Baru, Oana, et al.
Publicado: (2021)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

My COVID-19 dream: training enough health workers
por: Tulenko, Kate
Publicado: (2021)

Effects of Vaccination and Previous Infection on Omicron Infections in Children
por: Lin, Dan-Yu, et al.
Publicado: (2022)

Effectiveness of Bivalent Boosters against Severe Omicron Infection
por: Lin, Dan-Yu, et al.
Publicado: (2023)

The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022
por: Ling, Yun, et al.
Publicado: (2022)

Prevalence of Omicron variant during the third wave of COVID-19 at a tertiary care hospital in Western Maharashtra
por: Singh, S.P., et al.
Publicado: (2022)

Risk of omicron infection for high-risk older adults in long-term care facilities
por: Pallett, Scott J C, et al.
Publicado: (2023)

Emergence of Omicron sub-variant BA.2: Is it a matter of concern amid the COVID-19 pandemic?
por: Dhawan, Manish, et al.
Publicado: (2022)

COVID-19 in Brazil: far beyond biopolitics
por: Dall'Alba, Rafael, et al.
Publicado: (2021)

Recently emerged omicron subvariant BF.7 and its R346T mutation in the RBD region reveal increased transmissibility and higher resistance to neutralization antibodies: need to understand more under the current scenario of rising cases in China and fears of driving a new wave of the COVID-19 pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

COVID-19 vaccine efficacy data: solid enough to delay second dose?
por: Robertson, John F R, et al.
Publicado: (2021)

Evidence-Informed Policy-Making: Will It Ever Be Enough? A Response to the Recent Commentary
por: Al Sabahi, Sultana
Publicado: (2022)

African care for congenital central nervous system disorders: Falling far short of global management standards?
por: Wireko, Andrew A., et al.
Publicado: (2023)

Nursing Homes, the Pandemic, and Caring Enough
por: Gurwitz, Jerry H., et al.
Publicado: (2020)

Etripamil: Self-management of supraventricular tachycardia is not far away?
por: Faisaluddin, Mohammed, et al.
Publicado: (2019)

Opioids for Sedation: Has the Pendulum Swung Too Far?
por: Murray, Brian P., et al.
Publicado: (2021)

Evaluating Approaches to Improve Equity in Critical Care Resource Allocation in the COVID-19 Pandemic
por: Ross-Driscoll, Katherine, et al.
Publicado: (2021)

Addressing shame in medical professional identity: is there such a thing as a good enough doctor?
por: Broderick, Norella, et al.
Publicado: (2019)

Omicron: a challenge to hybrid immunity – correspondence
por: Niranjan, Ankush K., et al.
Publicado: (2023)

Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies
por: Sah, Ranjit, et al.
Publicado: (2023)

Rush Hour:Transform a modern hotel into cloud-based virtual ward care center within 80 hours under COVID-19 pandemic.Far eastern MemorialHospital's experience
por: Lim, Kai Xuan, et al.
Publicado: (2022)

Eosinopenia in COVID-19: What we missed so far?
por: Davido, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tsr3qf61afcit0h5j7kp331dbr